CSIMarket Company Name, Ticker, Suppliers, else..
 
Allurion Technologies Inc   (NYSE: ALUR)
Other Ticker:  
 
 
Price: $2.3800 $0.02 0.847%
Day's High: $2.42 Week Perf: 4.85 %
Day's Low: $ 2.33 30 Day Perf: -23.72 %
Volume (M): 30 52 Wk High: $ 88.75
Volume (M$): $ 71 52 Wk Avg: $16.77
Open: $2.36 52 Wk Low: $0.40



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 0
 Employees 137
 Revenues (TTM) (Millions $) 32
 Net Income (TTM) (Millions $) -26
 Cash Flow (TTM) (Millions $) -23
 Capital Exp. (TTM) (Millions $) 1

Allurion Technologies Inc
Allurion Technologies Inc is a medical device company that specializes in developing weight loss solutions. The company has created a non-surgical, swallowable gastric balloon known as the Elipse' Balloon, which is designed to help individuals lose weight by reducing their caloric intake and promoting early satiety.

The Elipse Balloon is ingested orally in a capsule form and then inflated within the stomach using a small tube attached to a balloon filling device. The procedure takes only a few minutes and does not require endoscopy or anesthesia.

Once in the stomach, the balloon occupies space, making the person feel fuller faster and restricting the amount of food that can be consumed. The device stays in the stomach for approximately four months, after which it is naturally expelled from the body.

Allurion Technologies aims to provide a safe and effective weight loss solution for individuals who are struggling with obesity or being overweight. Their approach offers a non-invasive alternative to surgical procedures like gastric bypass, making it a more appealing option for many patients.

The company is committed to conducting clinical studies, research, and development to improve the performance, safety, and efficacy of their gastric balloon technology. They work closely with healthcare professionals to ensure that their weight loss solutions are both effective and reliable.

Allurion Technologies has received recognition and approval from various regulatory bodies around the world for their innovative approach to weight loss. Their mission is to help people achieve sustainable weight loss and improve their quality of life.


   Company Address: 11 Huron Drive Natick 1760 MA
   Company Phone Number: 647-4000   Stock Exchange / Ticker: NYSE ALUR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX        1.24% 
BSX        1.68% 
DXCM        0.01% 
INMD   -7.45%    
ISRG        1.51% 
MDT        0.47% 
• View Complete Report
   



Business Update

Allurion Technologies Revamping Obesity Treatment with Dual-Action Innovation,

Published Fri, Mar 21 2025 7:29 PM UTC

Allurion Technologies: Pioneering a New Frontier in Obesity Treatment with Combined TherapiesIn the pursuit of innovative solutions to combat the global obesity crisis, Allurion Technologies, Inc. (NYSE: ALUR) is capturing attention with its promising new strategy that integrates the Allurion Balloon with low-dose GLP-1 therapy. This dynamic approach aims not only to enhanc...
Business Update

Transforming Weight Management Allurions Groundbreaking Fusion of Balloon Therapy and GLP-1 Treatment,

Published Fri, Mar 21 2025 11:36 AM UTC

Natick, Mass., Date Allurion Technologies, Inc. (NYSE: ALUR), a company at the forefront of combating obesity, recently announced promising initial results in the integration of its Allurion Program with low-dose GLP-1 therapy. This cutting-edge approach aims to not only enhance weight loss but also to preserve and optimize muscle mass while promoting adherence to GLP-1 t...
Business Update

Allurion Technologies Pioneering a New Era in Obesity Treatment with Innovative Combination Therapy

Published Tue, Feb 18 2025 4:17 PM UTC

In the ever-evolving landscape of healthcare solutions, Allurion Technologies, Inc. (NYSE: ALUR) is poised to make significant strides in the battle against obesity. Based in Natick, Massachusetts, Allurion is a forward-thinking company dedicated to tackling this global health challenge. In a bold move that underscores its commitment to innovation, Allurion recently announce...
Business Update

Allurion Technologies Aims to Enhance Muscle Mass During GLP-1 Therapy with New Clinical Study

Published Sat, Jan 25 2025 8:50 PM UTC

Natick, Mass. Allurion Technologies, Inc. (NYSE: ALUR), a company focused on combating obesity, has announced plans to conduct a clinical study that will explore the effects of combining its Allurion Program with GLP-1 agonists to enhance muscle mass and improve overall body composition. GLP-1 therapies, commonly used for weight loss, have previously shown to cause a redu...
Business Update

Allurion Technologies Pioneering New Heights in Obesity Treatment with Promising Trial Results,

Published Wed, Jan 8 2025 2:57 PM UTC

In a major milestone for the obesity treatment landscape, Allurion Technologies, Inc. (NYSE: ALUR) has unveiled promising topline results from its pivotal AUDACITY trial. This groundbreaking open-label, multicenter, randomized, controlled study is the first of its kind conducted in the United States to examine the efficacy and safety of an intragastric balloon for weight los...






Allurion Technologies Inc's Segments
Turkey    18.9 % of total Revenue
Australia    10.62 % of total Revenue
Italy    10 % of total Revenue
All Other Countries    65.49 % of total Revenue

  Allurion Technologies Inc Outlook

On April 30 2024 the Allurion Technologies Inc provided following guidance

Allurion Technologies, Inc. (Allurion or the Company) based in Natick, Massachusetts, has released preliminary unaudited results for the first quarter of 2024. The company, focused on combating obesity, anticipates revenue between $9.2 million to $9.3 ...





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com